Obstetrics & Gynecology, 93(4), S42, 1999
Etiologic Factors in Women with a History of Recurrent Pregnancy Loss
Author affiliations
- University of Tennessee Health Science Center ROR
Abstract not indexed. Read at source
recurrent pregnancy loss etiologic factors evaluation, recurrent miscarriage causes diagnostic workup, Kutteh recurrent pregnancy loss etiology women, habitual abortion causes antiphospholipid syndrome uterine anomaly, repeated miscarriage chromosomal hormonal immunological factors, recurrent spontaneous abortion risk factors evaluation, pregnancy loss thrombophilia luteal phase defect etiology, recurrent miscarriage comprehensive evaluation causes, multiple pregnancy loss immunologic genetic endocrine factors, recurrent abortion clinical evaluation treatment approach
DOI 10.1016/s0029-7844(99)90089-3 10.1016/s0029-7844(99)90089-3 Kutteh et al. 1999, Kutteh 1999
Cite this article
Kutteh, W. H., & Carney, G. L. (1999). Etiologic Factors in Women with a History of Recurrent Pregnancy Loss. Obstetrics & Gynecology, 93(4), S42. https://doi.org/10.1016/s0029-7844(99)90089-3
Kutteh WH, Carney GL. Etiologic Factors in Women with a History of Recurrent Pregnancy Loss. Obstetrics & Gynecology. 1999;93(4):S42. doi:10.1016/s0029-7844(99)90089-3
Kutteh, W. H., and G. L. Carney. "Etiologic Factors in Women with a History of Recurrent Pregnancy Loss." Obstetrics & Gynecology, vol. 93, no. 4, 1999, pp. S42.
Related articles
Diagnosis · Staging and Classification
Comprehensive Review of Endometriosis Care
Carey ET et al., 2025 · Obstetrics & Gynecology
Endometriosis is an estrogen-dependent, chronic inflammatory disorder characterized by the presence of endometrium-like tissue outside the uterus, affecting approximately 10% of individuals of reproductive age. It contributes to chronic pelvic pain, dysmenorrhea, and subfertility, resulting in substantial societal economic burdens. Genetic and environmental risk factors have been identified, and recent research suggests that endometriosis functions as a systemic disease affecting nonreproductive systems and increasing susceptibility to other health conditions. Various phenotypes-superficial peritoneal endometriosis, ovarian endometriomas, and deep endometriosis-may develop under different mechanisms, yet the relationship between these presentations remains unclear. Diagnosis relies on clinical evaluation, imaging, and surgical staging, and the advent of advanced ultrasonography and magnetic resonance imaging has helped to enhance accuracy. Although medical management focuses on hormonal modulation to alleviate symptoms, surgical intervention remains a critical tool for refractory symptoms. Postoperative care and patient education are essential to manage recurrence and to improve quality of life. Current research emphasizes the need for comprehensive, interdisciplinary approaches to endometriosis management, incorporating novel diagnostic tools, diverse therapeutic avenues, and patient-centered care models. Addressing disparities in treatment access is essential to improving outcomes. To achieve this, recruiting and analyzing data from racially, socioeconomically, and geographically diverse cohorts will reveal how disease presentation and treatment efficacy vary across populations. Continued efforts in research and health care policy are necessary to develop effective and personalized strategies in managing endometriosis.
Guidelines by Clinical Area · Obstetric Guidelines
Obstetric Care Consensus No. 7: Placenta Accreta Spectrum
American College of Obstetricians and Gynecologists et al., 2018 · Obstetrics & Gynecology
Placenta accreta spectrum, formerly known as morbidly adherent placenta, refers to the range of pathologic adherence of the placenta, including placenta increta, placenta percreta, and placenta accreta. The most favored hypothesis regarding the etiology of placenta accreta spectrum is that a defect of the endometrial-myometrial interface leads to a failure of normal decidualization in the area of a uterine scar, which allows abnormally deep placental anchoring villi and trophoblast infiltration. Maternal morbidity and mortality can occur because of severe and sometimes life-threatening hemorrhage, which often requires blood transfusion. Although ultrasound evaluation is important, the absence of ultrasound findings does not preclude a diagnosis of placenta accreta spectrum; thus, clinical risk factors remain equally important as predictors of placenta accreta spectrum by ultrasound findings. There are several risk factors for placenta accreta spectrum. The most common is a previous cesarean delivery, with the incidence of placenta accreta spectrum increasing with the number of prior cesarean deliveries. Antenatal diagnosis of placenta accreta spectrum is highly desirable because outcomes are optimized when delivery occurs at a level III or IV maternal care facility before the onset of labor or bleeding and with avoidance of placental disruption. The most generally accepted approach to placenta accreta spectrum is cesarean hysterectomy with the placenta left in situ after delivery of the fetus (attempts at placental removal are associated with significant risk of hemorrhage). Optimal management involves a standardized approach with a comprehensive multidisciplinary care team accustomed to management of placenta accreta spectrum. In addition, established infrastructure and strong nursing leadership accustomed to managing high-level postpartum hemorrhage should be in place, and access to a blood bank capable of employing massive transfusion protocols should help guide decisions about delivery location.
Trying to Conceive After an Early Pregnancy Loss: An Assessment on How Long Couples Should Wait
Giovane R et al., 2016 · Obstetrics & Gynecology · Open Access
Our study supports the hypothesis that there is no physiologic evidence for delaying pregnancy attempt after an early loss.
Ovarian Surgery · Ovarian Reserve Preservation
Anti-N-methyl-aspartate receptor encephalitis in identical twin sisters: role for oophorectomy
Masghati S et al., 2014 · Obstetrics & Gynecology
Anti-N-methyl-aspartate receptor encephalitis is a potentially fatal form of encephalitis and frequently associated with ovarian teratomas. Surgical removal of ovarian teratomas improves clinical outcome, but it is unclear whether bilateral salpingo-oophorectomy for normal-appearing ovaries is of clinical benefit. Our report describes a unique clinical scenario of identical twin sisters with anti-N-methyl-aspartate receptor encephalitis. Neither patient responded to immunosuppressive therapy. Imaging studies showed normal-appearing ovaries. The first twin continued on medical therapy only and died of the disease. The second twin underwent a bilateral salpingo-oophorectomy followed by gradual recovery. Based on our experience in two genetically identical individuals, we suggest considering the removal of normal-appearing ovaries in patients with anti-N-methyl-aspartate receptor encephalitis who fail to respond to medical treatment.